Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
bristol-myers squibb
7
×
life sciences
national blog main
national top stories
startups
7
×
san diego blog main
san diego top stories
san francisco blog main
boston blog main
boston top stories
boulder/denver blog main
boulder/denver top stories
cancer
clinical trials
detroit blog main
detroit top stories
eli lilly
indiana blog main
indiana top stories
national
new york blog main
new york top stories
raleigh-durham blog main
raleigh-durham top stories
san francisco top stories
seattle blog main
seattle top stories
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
cancer immunotherapy
deals
fda
pfizer
abbvie
alzheimer's disease
biogen
glaxosmithkline
What
bio
roundup
drug
biotech
bristol
cancer
companies
growing
investment
nash
new
news
raised
alliance
alzheimer’s
amsterdam
annual
appetite
approval
approved
assessed
athena
attention
biogen’s
biopharmaceutical
black
board
bread
butter
buy
buyout
calls
cash
ceo
changing
chief
color
communities
conference
convo
Language
unset
Current search:
startups
×
" bristol-myers squibb "
×
@xconomy.com
3 years ago
Bio Roundup: CRISPR Kudos, Bristol Myers’s Buy, RNAi Alliance & More
@xconomy.com
4 years ago
With Bristol and Otsuka on Board, LSP Raises $620M EU Life Sciences Fund
@xconomy.com
5 years ago
Bio Roundup: Biogen’s Strategy, Drug Price Convo, NASH News & More
@xconomy.com
5 years ago
Bio Roundup: NASH News, Merck Strikes, Digital Tokens & More
@xconomy.com
5 years ago
Bio Roundup: #JPM19 Notes, Loxo Buyout, Black Diamond’s Cash & More
@xconomy.com
5 years ago
Bio Roundup: Alzheimer’s Puzzle, ESMO Assessed, Drug Prices & More
@xconomy.com
5 years ago
TP Therapeutics Names New CEO, Gets $80M More For Cancer Drug Push